03869 弘和仁愛醫療
按盘价 
4.500 0.000 (0.000%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 5.326% | -17.303% | -8.175% | -9.863% | 3.653% |
| 股东资金回报率 (%) | 41.394% | -91.289% | -29.892% | -31.549% | 10.750% |
| 资本运用回报率 (%) | 7.407% | -74.011% | -10.806% | -12.391% | 3.809% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 16.765% | 13.201% | 41.175% | 48.678% | 42.315% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 19.427% | -41.534% | -75.713% | -89.410% | 53.752% |
| 税前边际利润率 (%) | 15.143% | -46.601% | -86.318% | -109.170% | 47.597% |
| 纯利率 (%) | 9.202% | -42.079% | -53.952% | -101.285% | 36.726% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.311 X | 0.472 X | 2.235 X | 2.631 X | 2.592 X |
| 速动比率 (X) | 1.240 X | 0.440 X | 2.144 X | 2.617 X | 2.581 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 76.334% | 81.794% | 63.639% | 63.484% | 59.195% |
| 总债项 / 总资产比率 (%) | 41.202% | 45.312% | 37.507% | 45.160% | 42.894% |
| 净债项 / 总资产比率 (%) | 20.265% | 24.904% | 23.407% | 22.172% | 24.114% |
| 总债项 / 股东资金比率 (%) | 271.508% | 431.584% | 146.823% | 156.542% | 128.844% |
| 长期债项 / 股东资金比率 (%) | 249.380% | 2.440% | 125.344% | 147.509% | 120.945% |
| 净债项 / 股东资金比率 (%) | 133.540% | 237.199% | 91.630% | 76.857% | 72.434% |
| 净现金 / (债项) ($) | (5.06亿) | (6.07亿) | (7.31亿) | (8.30亿) | (10.74亿) |
| 每股净现金 / (债项) ($) | (3.663) | (4.389) | (5.291) | (6.007) | (7.774) |
| 总债项 / 资本运用比率 (%) | 58.030% | 169.828% | 45.102% | 51.819% | 48.230% |
| 利息盈利率 (X) | 49.948 X | N/A | N/A | N/A | 14.299 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 16.661日 | 19.334日 | 32.553日 | 10.316日 | 10.537日 |
| 应收贸易帐周转率日数 (日) | 26.229日 | 29.753日 | 52.173日 | 29.384日 | 28.495日 |
| 应付贸易帐周转率日数 (日) | 36.737日 | 41.700日 | 49.480日 | 13.754日 | 13.418日 |
| 备注： | 实时报价更新时间为04/10/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -18,718,000 |
| 增长率 | -- |
| 每股盈利/(亏损) | RMB -0.140 |
| 每股账面资产净值 (¥) | RMB 2.608 |